Keeping Patients Well: CEPROSH Champions Adherence to Therapy


	In the Dominican Republic, approximately 66,000 people are living with HIV/AIDS. Extreme poverty, gender inequalities and high levels of immigration from nearby Haiti contribute to the epidemic. In addition, when women face financial stress, they often turn to the sex trade for money and goods, and this increases their chances of being infected. To address the epidemic in the Dominican Republic, the non-governmental organization Centro de Promoción y Solidaridad Humana (CEPROSH) provides educational, emotional and community support for people living with HIV/AIDS. “We offer workshops for families, self-help groups, home and hospital visits, and training for health care workers,” says Bayardo Gomez, M.D., Executive Director of CEPROSH. “We’ve made good progress, especially in the area of helping people adhere to treatment with antiretroviral (ARV) therapies.” Based in Puerto Plata, Dominican Republic, CEPROSH provides ARV therapy to over 400 patients, as well as follow-up treatment to more than 850 HIV-positive individuals who do not require ARV therapy. The organization recently expanded its activities to the care of patients in La Vega, Nagua, Dajabon and Mao, communities that are close to the Haitian border. Johnson & Johnson provides support for the Adherencia Plus program, which is managed by CEPROSH in coordination with the non-governmental organization Fundación Genesis. “Every day, an increasing number of people arrive at health centers without sufficient information and follow-up needed to maintain their adherence to ARV treatments,” says Dr. Gomez. “CEPROSH trains and distributes information to people at these centers and the people living with HIV/AIDS in the areas they serve.” The Adherencia Plus program has reached more than 4,200 disadvantaged individuals suffering from HIV/AIDS, their relatives and other community members from Puerto Plata and Santa Domingo. The results are impressive: “Fewer people are abandoning their treatments. The beneficiaries of our programs are in excellent condition and are receiving the care they need,” says Dr. Gomez.

Content for users without Flash here.

Employees

This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2013. All Rights Reserved.

Johnson & Johnson

Home > Our Caring > Our Giving > Preventing Diseases > HIV/AIDS Portfolio > Strengthening Supportive Care & Service

Keeping Patients Well: CEPROSH Champions Adherence to Therapy

	In the Dominican Republic, approximately 66,000 people are living with HIV/AIDS. Extreme poverty, gender inequalities and high levels of immigration from nearby Haiti contribute to the epidemic. In addition, when women face financial stress, they often turn to the sex trade for money and goods, and this increases their chances of being infected. To address the epidemic in the Dominican Republic, the non-governmental organization Centro de Promoción y Solidaridad Humana (CEPROSH) provides educational, emotional and community support for people living with HIV/AIDS. “We offer workshops for families, self-help groups, home and hospital visits, and training for health care workers,” says Bayardo Gomez, M.D., Executive Director of CEPROSH. “We’ve made good progress, especially in the area of helping people adhere to treatment with antiretroviral (ARV) therapies.” Based in Puerto Plata, Dominican Republic, CEPROSH provides ARV therapy to over 400 patients, as well as follow-up treatment to more than 850 HIV-positive individuals who do not require ARV therapy. The organization recently expanded its activities to the care of patients in La Vega, Nagua, Dajabon and Mao, communities that are close to the Haitian border. Johnson & Johnson provides support for the Adherencia Plus program, which is managed by CEPROSH in coordination with the non-governmental organization Fundación Genesis. “Every day, an increasing number of people arrive at health centers without sufficient information and follow-up needed to maintain their adherence to ARV treatments,” says Dr. Gomez. “CEPROSH trains and distributes information to people at these centers and the people living with HIV/AIDS in the areas they serve.” The Adherencia Plus program has reached more than 4,200 disadvantaged individuals suffering from HIV/AIDS, their relatives and other community members from Puerto Plata and Santa Domingo. The results are impressive: “Fewer people are abandoning their treatments. The beneficiaries of our programs are in excellent condition and are receiving the care they need,” says Dr. Gomez.

In the Dominican Republic, approximately 66,000 people are living with HIV/AIDS. Extreme poverty, gender inequalities and high levels of immigration from nearby Haiti contribute to the epidemic. In addition, when women face financial stress, they often turn to the sex trade for money and goods, and this increases their chances of being infected.

To address the epidemic in the Dominican Republic, the non-governmental organization Centro de Promoción y Solidaridad Humana (CEPROSH) provides educational, emotional and community support for people living with HIV/AIDS.

“We offer workshops for families, self-help groups, home and hospital visits, and training for health care workers,” says Bayardo Gomez, M.D., Executive Director of CEPROSH. “We’ve made good progress, especially in the area of helping people adhere to treatment with antiretroviral (ARV) therapies.”

Based in Puerto Plata, Dominican Republic, CEPROSH provides ARV therapy to over 400 patients, as well as follow-up treatment to more than 850 HIV-positive individuals who do not require ARV therapy. The organization recently expanded its activities to the care of patients in La Vega, Nagua, Dajabon and Mao, communities that are close to the Haitian border.

Johnson & Johnson provides support for the Adherencia Plus program, which is managed by CEPROSH in coordination with the non-governmental organization Fundación Genesis. “Every day, an increasing number of people arrive at health centers without sufficient information and follow-up needed to maintain their adherence to ARV treatments,” says Dr. Gomez. “CEPROSH trains and distributes information to people at these centers and the people living with HIV/AIDS in the areas they serve.”

The Adherencia Plus program has reached more than 4,200 disadvantaged individuals suffering from HIV/AIDS, their relatives and other community members from Puerto Plata and Santa Domingo. The results are impressive: “Fewer people are abandoning their treatments. The beneficiaries of our programs are in excellent condition and are receiving the care they need,” says Dr. Gomez.

Employees